Financial News

Recent Quotes

My Watchlist

Indicators

Overview

KILL ViroCell Signs Manufacturing Services Agreement with UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer

By: Business Wire

December 13, 2023 at 15:26 PM EST

ViroCell Biologics requests that their press release NewsItemId: 20231211079092 issued December 12, 2023 “ViroCell Signs Manufacturing Services Agreement with UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer” be killed.

The release was issued prematurely by ViroCell Biologics.

Contacts

For more company information, please contact:

ViroCell

John W. Hadden II, CEO

info@virocell.com

For media enquiries, please contact:

FTI Consulting

Simon Conway / Victoria Foster Mitchell / Tim Stamper

ViroCell@fticonsulting.com

+44 (0)20 3727 1000

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

KILL ViroCell Signs Manufacturing Services Agreement with UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer

Contacts

Popular Pages